查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1942574

2026年全球克隆與誘變市場報告

Cloning And Mutagenesis Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，克隆和誘變技術的市場規模迅速擴張，預計將從2025年的35.4億美元成長到2026年的42.1億美元，複合年成長率達19.1%。過去幾年的成長可歸因於多種因素，例如學術研究經費的增加、重組蛋白研究的進步、基因工程工具的廣泛應用、標準化分子生物學試劑盒的普及以及生物技術Start-Ups企業的增加。

預計未來幾年克隆和誘變市場將快速成長，到2030年市場規模將達到85億美元，複合年成長率（CAGR）為19.2%。預測期內的成長預計將受到以下因素的驅動：基因功能研究需求的增加、合成生物學應用的拓展、治療性蛋白質開發投資的增加、自動化實驗室平台的普及以及對精準基因組編輯的日益重視。預測期內的關鍵趨勢包括：高精度克隆試劑盒的廣泛應用、特異性誘變技術的日益普及、對基於CRISPR的編輯工具的需求不斷成長、自動化分子生物學工作流程的擴展以及對可重複性和準確性的日益重視。

由於對個人化醫療的需求不斷成長，克隆和誘變市場預計將持續成長。個人化醫療是一種創新的醫療方法，它根據每位患者的獨特特徵量身定做醫療程序和干涉措施。克隆和誘變在個人化醫療的各個方面都發揮關鍵作用，包括疾病建模、藥物發現、目標分子識別、基因治療、生物標記發現、患者特異性細胞治療、藥物基因組學以及用於個人化治療的基因組編輯。例如，據美國非營利組織「個人化醫療聯盟」（Personalized Medicine Coalition）稱，截至2024年2月，美國食品藥物管理局（FDA）在2023年核准了16種用於治療罕見疾病患者的新型個人化療法，較2022年的6種核准顯著增加。這種對個人化醫療日益成長的需求是推動克隆和誘變技術市場成長的關鍵因素。

為了維持競爭優勢，克隆和誘變市場的主要企業也積極探索聚合酵素鏈鎖反應（PCR）等創新技術。 PCR是一種分子生物學實驗室技術，用於擴增特定的DNA片段。美國生技公司Bio-Rad Laboratories於2023年4月推出了ID-Check物種鑑定解決方案。這種即時PCR方法支持肉類物種鑑定，並能夠識別食品、飼料和環境樣本中的動物物種。它提供了一種可靠、快速的原料來源檢驗方法，並能提升生產線的清潔效率。此解決方案以極高的靈敏度靶向各種肉類物種的粒線體DNA，可檢測到濃度低至0.001%的DNA。它採用雙重檢測系統，兼顧準確性和用戶便利性。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球克隆與誘變市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧和自主智慧
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網 (IoT)、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 擴大高精度克隆試劑盒的使用範圍
    • 定點特異性技術的日益普及
    • 對基於 CRISPR 的基因編輯工具的需求不斷成長
    • 擴展自動化分子生物學工作流程
    • 更加重視可重複性和準確性

第5章 終端用戶產業市場分析

  • 學術研究機構
  • 生技公司
  • 製藥公司
  • 合約研究機構
  • 合成生物學公司

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球克隆與誘變市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球克隆和誘變市場規模、比較和成長率分析
  • 全球克隆與誘變市場表現：規模與成長，2020-2025年
  • 全球克隆和誘變市場預測：規模和成長，2025-2030年，2035年預測

第8章 全球潛在市場總量（TAM）

第9章 市場細分

  • 依產品
  • 克隆試劑盒、誘變試劑盒及其他產品
  • 透過技術
  • 平末端克隆、拓樸PCR克隆、無縫克隆、特異性突變、其他技術、基於CRISPR的基因編輯
  • 最終用戶
  • 學術研究機構、生物技術公司和其他最終用戶
  • 按類型細分：克隆試劑盒
  • 細菌克隆試劑盒、酵母克隆試劑盒、病毒克隆試劑盒、質體克隆試劑盒
  • 依類型細分：誘變試劑盒
  • 特異性誘變試劑盒、隨機誘變試劑盒、錯誤誘導PCR試劑盒、CRISPR或Cas9誘變試劑盒
  • 按類型細分：其他產品
  • 酵素、載體系統和配件

第10章 區域與國家分析

  • 全球克隆與誘變市場：按地區、業績和預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球克隆與誘變市場：按國家分類，實際結果和預測，2020-2025 年、2025-2030 年預測、2035 年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 克隆與誘變市場：競爭格局與市佔率（2024年）
  • 克隆與誘變市場：公司估值矩陣
  • 克隆與誘變市場：公司概況
    • Thermo Fisher Scientific Inc
    • Takara Bio Inc
    • Agilent Technologies Inc
    • New England Biolabs Inc
    • Merck KGaA

第37章：其他領先和創新企業

  • Promega Corporation, Bio-Rad Laboratories Inc, GenScript Biotech Corporation, Codex DNA Inc, Integrated DNA Technologies Inc, Bio-Techne Corporation, Sino Biological Inc, OriGene Technologies Inc, Bioneer Corporation, Lucigen Corporation, Inscripta Inc, Creative Biogene, Biomatik Corporation, TransGen Biotech Co Ltd, Jena Bioscience GmbH

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年克隆與誘變市場：提供新機會的國家
  • 克隆與誘變市場展望 2030：充滿新機會的細分市場
  • 克隆和誘變市場 2030：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MCMUT01_G26Q1

Cloning and mutagenesis are integral techniques within molecular biology that involve the replication of multiple identical copies of a DNA fragment, gene, or entire genome, along with the introduction of mutations into a DNA sequence. These techniques play a crucial role in studying gene function and regulation, facilitating the development of new drugs and therapeutics, and producing recombinant enzymes and proteins.

The primary products associated with cloning and mutagenesis include cloning kits, mutagenesis kits, and other related tools. Cloning kits are specialized laboratory instruments designed to streamline the process of cloning specific DNA fragments or genes into a cloning vector. These kits are essential for various cloning experiments, including gene cloning, subcloning, site-directed mutagenesis, and library construction. Techniques such as blunt end cloning, topo PCR cloning, seamless cloning, site-directed mutagenesis, among others, are employed by academic and research institutions, biotechnology companies, and other entities engaged in molecular biology research.

Tariffs are impacting the cloning and mutagenesis market by increasing costs of imported enzymes, reagents, vectors, specialized plastics, and laboratory automation components. Research institutes and biotechnology companies in North America and Europe are most affected due to dependence on imported consumables, while Asia-Pacific faces cost pressure on kit manufacturing and exports. These tariffs are raising research operating costs and procurement cycles. However, they are also supporting domestic reagent production, regional supplier expansion, and localized manufacturing of molecular biology tools.

The cloning and mutagenesis market research report is one of a series of new reports from The Business Research Company that provides cloning and mutagenesis market statistics, including cloning and mutagenesis industry global market size, regional shares, competitors with a cloning and mutagenesis market share, detailed cloning and mutagenesis market segments, market trends and opportunities, and any further data you may need to thrive in the cloning and mutagenesis industry. This cloning and mutagenesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cloning and mutagenesis market size has grown rapidly in recent years. It will grow from $3.54 billion in 2025 to $4.21 billion in 2026 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to expansion of academic research funding, growth of recombinant protein research, increasing use of genetic engineering tools, availability of standardized molecular biology kits, rise of biotech startup activity.

The cloning and mutagenesis market size is expected to see rapid growth in the next few years. It will grow to $8.5 billion in 2030 at a compound annual growth rate (CAGR) of 19.2%. The growth in the forecast period can be attributed to increasing demand for gene function studies, expansion of synthetic biology applications, rising investments in therapeutic protein development, growing adoption of automated lab platforms, increasing focus on precision genome editing. Major trends in the forecast period include increasing adoption of high-fidelity cloning kits, rising use of site-directed mutagenesis techniques, growing demand for crispr-based editing tools, expansion of automated molecular biology workflows, enhanced focus on reproducibility and accuracy.

The cloning and mutagenesis market is anticipated to grow due to the increasing demand for personalized medicine. Personalized medicine is an innovative healthcare approach that tailors medical treatment and interventions to the unique characteristics of each patient. Cloning and mutagenesis play crucial roles in various aspects of personalized medicine, such as disease modeling, drug development, target identification, gene therapy, biomarker discovery, patient-specific cell therapies, pharmacogenomics, and genome editing for personalized therapies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized therapies for patients with rare diseases, marking a substantial rise from the six approvals recorded in 2022. This increasing demand for personalized medicine is a significant driver of the growth in the cloning and mutagenesis market.

Leading companies in the cloning and mutagenesis markets are also actively exploring innovative techniques such as Polymerase Chain Reaction (PCR) to maintain a competitive edge. PCR is a molecular biology laboratory technique that amplifies specific DNA segments. Bio-Rad Laboratories, Inc., a US-based biotech company, launched the ID-Check Speciation Solution in April 2023. This real-time PCR method aids in meat speciation, allowing the identification of animal species in food, feed, and environmental samples. It provides a reliable and rapid means to verify raw material origins, enhancing production line cleaning processes. The solution targets mitochondrial DNA from various meat species with exceptional sensitivity, detecting DNA concentrations as low as 0.001%. It features a duplex detection system for accuracy and user convenience.

n March 2023, Sartorius AG, a Germany-based multinational life science company, acquired Polyplus Transfection SA for an undisclosed amount. Through this acquisition, Sartorius intends to broaden its upstream portfolio for cell and gene therapy manufacturing by incorporating Polyplus's transfection reagents, nucleic acid delivery technologies, and GMP-grade plasmid DNA capabilities to support viral vector production and plasmid workflows essential to gene modification research and GMP applications. Polyplus Transfection SA, a France-based company, offers services related to cloning and mutagenesis.

Major companies operating in the cloning and mutagenesis market are Thermo Fisher Scientific Inc, Takara Bio Inc, Agilent Technologies Inc, New England Biolabs Inc, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc, GenScript Biotech Corporation, Codex DNA Inc, Integrated DNA Technologies Inc, Bio-Techne Corporation, Sino Biological Inc, OriGene Technologies Inc, Bioneer Corporation, Lucigen Corporation, Inscripta Inc, Creative Biogene, Biomatik Corporation, TransGen Biotech Co Ltd, Jena Bioscience GmbH, EZBioscience, Synbio Technologies LLC

North America was the largest region in the cloning and mutagenesis market in 2025. Asia-pacific is expected to be the fastest-growing region in the global cloning and mutagenesis market report during the forecast period. The regions covered in the cloning and mutagenesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cloning and mutagenesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cloning and mutagenesis market includes revenues earned by entities by assay kits, biotin-peg linkers, Bira proteins, and cells. The market value includes the value of related goods sold by the service provider or included within the service offering. The cloning and mutagenesis market also includes of sales of techniques such as the isolation of DNA, cloning vectors, and DNA ligase. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cloning And Mutagenesis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cloning and mutagenesis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cloning and mutagenesis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cloning and mutagenesis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Cloning Kits; Mutagenesis Kits; Other Products
  • 2) By Technique: Blunt End Cloning; Topo PCR Cloning; Seamless Cloning; Site-Directed Mutagenesis; Other Techniques
  • 3) By End User: Academic and Research Institutes; Biotechnology Companies; Other End Users
  • Subsegments:
  • 1) By Cloning Kits: Bacterial Cloning Kits; Yeast Cloning Kits; Viral Cloning Kits; Plasmid Cloning Kits
  • 2) By Mutagenesis Kits: Site-Directed Mutagenesis Kits; Random Mutagenesis Kits; Error-Prone PCR Kits; CRISPR Or Cas9 Mutagenesis Kits
  • 3) By Other Products: Enzymes; Vector Systems; Accessories
  • Companies Mentioned: Thermo Fisher Scientific Inc; Takara Bio Inc; Agilent Technologies Inc; New England Biolabs Inc; Merck KGaA; Promega Corporation; Bio-Rad Laboratories Inc; GenScript Biotech Corporation; Codex DNA Inc; Integrated DNA Technologies Inc; Bio-Techne Corporation; Sino Biological Inc; OriGene Technologies Inc; Bioneer Corporation; Lucigen Corporation; Inscripta Inc; Creative Biogene; Biomatik Corporation; TransGen Biotech Co Ltd; Jena Bioscience GmbH; EZBioscience; Synbio Technologies LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Cloning And Mutagenesis Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Cloning And Mutagenesis Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Cloning And Mutagenesis Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Cloning And Mutagenesis Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics And Precision Medicine
    • 4.1.2 Artificial Intelligence And Autonomous Intelligence
    • 4.1.3 Industry 4.0 And Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of High-Fidelity Cloning Kits
    • 4.2.2 Rising Use Of Site-Directed Mutagenesis Techniques
    • 4.2.3 Growing Demand For Crispr-Based Editing Tools
    • 4.2.4 Expansion Of Automated Molecular Biology Workflows
    • 4.2.5 Enhanced Focus On Reproducibility And Accuracy

5. Cloning And Mutagenesis Market Analysis Of End Use Industries

  • 5.1 Academic And Research Institutes
  • 5.2 Biotechnology Companies
  • 5.3 Pharmaceutical Companies
  • 5.4 Contract Research Organizations
  • 5.5 Synthetic Biology Firms

6. Cloning And Mutagenesis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cloning And Mutagenesis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Cloning And Mutagenesis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Cloning And Mutagenesis Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Cloning And Mutagenesis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Cloning And Mutagenesis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cloning And Mutagenesis Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cloning And Mutagenesis Market Segmentation

  • 9.1. Global Cloning And Mutagenesis Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cloning Kits, Mutagenesis Kits, Other Products
  • 9.2. Global Cloning And Mutagenesis Market, Segmentation By Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blunt End Cloning, Topo PCR Cloning, Seamless Cloning, Site-Directed Mutagenesis, Other Techniques, CRISPR-Based Editing
  • 9.3. Global Cloning And Mutagenesis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Academic And Research Institutes, Biotechnology Companies, Other End Users
  • 9.4. Global Cloning And Mutagenesis Market, Sub-Segmentation Of Cloning Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bacterial Cloning Kits, Yeast Cloning Kits, Viral Cloning Kits, Plasmid Cloning Kits
  • 9.5. Global Cloning And Mutagenesis Market, Sub-Segmentation Of Mutagenesis Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Site-Directed Mutagenesis Kits, Random Mutagenesis Kits, Error-Prone PCR Kits, CRISPR Or Cas9 Mutagenesis Kits
  • 9.6. Global Cloning And Mutagenesis Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzymes, Vector Systems, Accessories

10. Cloning And Mutagenesis Market Regional And Country Analysis

  • 10.1. Global Cloning And Mutagenesis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Cloning And Mutagenesis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cloning And Mutagenesis Market

  • 11.1. Asia-Pacific Cloning And Mutagenesis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cloning And Mutagenesis Market

  • 12.1. China Cloning And Mutagenesis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cloning And Mutagenesis Market

  • 13.1. India Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cloning And Mutagenesis Market

  • 14.1. Japan Cloning And Mutagenesis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cloning And Mutagenesis Market

  • 15.1. Australia Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cloning And Mutagenesis Market

  • 16.1. Indonesia Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cloning And Mutagenesis Market

  • 17.1. South Korea Cloning And Mutagenesis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cloning And Mutagenesis Market

  • 18.1. Taiwan Cloning And Mutagenesis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cloning And Mutagenesis Market

  • 19.1. South East Asia Cloning And Mutagenesis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cloning And Mutagenesis Market

  • 20.1. Western Europe Cloning And Mutagenesis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cloning And Mutagenesis Market

  • 21.1. UK Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cloning And Mutagenesis Market

  • 22.1. Germany Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cloning And Mutagenesis Market

  • 23.1. France Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cloning And Mutagenesis Market

  • 24.1. Italy Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cloning And Mutagenesis Market

  • 25.1. Spain Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cloning And Mutagenesis Market

  • 26.1. Eastern Europe Cloning And Mutagenesis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cloning And Mutagenesis Market

  • 27.1. Russia Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cloning And Mutagenesis Market

  • 28.1. North America Cloning And Mutagenesis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cloning And Mutagenesis Market

  • 29.1. USA Cloning And Mutagenesis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cloning And Mutagenesis Market

  • 30.1. Canada Cloning And Mutagenesis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cloning And Mutagenesis Market

  • 31.1. South America Cloning And Mutagenesis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cloning And Mutagenesis Market

  • 32.1. Brazil Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cloning And Mutagenesis Market

  • 33.1. Middle East Cloning And Mutagenesis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cloning And Mutagenesis Market

  • 34.1. Africa Cloning And Mutagenesis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Cloning And Mutagenesis Market, Segmentation By Product, Segmentation By Technique, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cloning And Mutagenesis Market Regulatory and Investment Landscape

36. Cloning And Mutagenesis Market Competitive Landscape And Company Profiles

  • 36.1. Cloning And Mutagenesis Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Cloning And Mutagenesis Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Cloning And Mutagenesis Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Takara Bio Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Agilent Technologies Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. New England Biolabs Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

37. Cloning And Mutagenesis Market Other Major And Innovative Companies

  • Promega Corporation, Bio-Rad Laboratories Inc, GenScript Biotech Corporation, Codex DNA Inc, Integrated DNA Technologies Inc, Bio-Techne Corporation, Sino Biological Inc, OriGene Technologies Inc, Bioneer Corporation, Lucigen Corporation, Inscripta Inc, Creative Biogene, Biomatik Corporation, TransGen Biotech Co Ltd, Jena Bioscience GmbH

38. Global Cloning And Mutagenesis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cloning And Mutagenesis Market

40. Cloning And Mutagenesis Market High Potential Countries, Segments and Strategies

  • 40.1 Cloning And Mutagenesis Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Cloning And Mutagenesis Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Cloning And Mutagenesis Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer